BG Medicine to Present at Lazard Capital Markets 9th Annual Healthcare Conference

Published: Nov 12, 2012

WALTHAM, Mass., Nov. 9, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today that Eric Bouvier, BG Medicine's President and CEO, will present at the Lazard Capital Markets 9th Annual Healthcare Conference on November 14 at 3:00 PM Eastern Time (ET) in New York City.

Back to news